Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Regulatory News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 22.00
Ask: 26.00
Change: 0.00 (0.00%)
Spread: 4.00 (18.182%)
Open: 24.00
High: 0.00
Low: 0.00
Prev. Close: 24.00
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

10 Nov 2023 10:14

RNS Number : 0964T
Oncimmune Holdings PLC
10 November 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYQ94H38

Issuer Name

ONCIMMUNE HOLDINGS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Spreadex LTD

City of registered office (if applicable)

St. Albans

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

08-Nov-2023

6. Date on which Issuer notified

09-Nov-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

2.485800

3.665100

6.150900

4560383

Position of previous notification (if applicable)

1.926100

4.049200

5.975300

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BYQ94H38

1843032

2.485800

Sub Total 8.A

1843032

2.485800%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

CFD/Spreadbet

2717351

3.665100

Sub Total 8.B1

2717351

3.665100%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

09-Nov-2023

13. Place Of Completion

UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLBMBMTMTBBBJJ
Date   Source Headline
13th Aug 202011:38 amRNSExercise of Options and Total Voting Rights
12th Aug 20207:00 amRNSAppointment of Joint Brokers
10th Aug 20207:00 amRNSEarlyCDT Lung Blood Test Featured on ITV News
7th Aug 20207:00 amRNSExercise of Options and Total Voting Rights
5th Aug 20207:00 amRNSFurther evidence for the use of the EarlyCDT Lung
31st Jul 20207:00 amRNSERJ publishes results from the ECLS study
27th Jul 20207:00 amRNSRoche Contract Expansion to Profile Autoantibodies
24th Jul 20202:52 pmRNSExercise of Options and Total Voting Rights
8th Jul 20207:00 amRNSPaper highlights potential of ImmunoINSIGHTS in RA
1st Jul 20207:00 amRNSAuthorisation for EarlyCDT Lung in Brazil
30th Jun 20207:00 amRNSExercise of Options
9th Jun 20203:54 pmRNSGrant of Options and PDMR notification
8th Jun 20207:00 amRNSHoldings in Company
5th Jun 20202:00 pmRNSPrice Monitoring Extension
5th Jun 20209:02 amRNSCORRECTION: Director/PDMR's Dealing
5th Jun 20207:00 amRNSDirector/PDMR's Dealing
4th Jun 20207:00 amRNSTrading Update for 12 months to 31 May 2020
2nd Jun 20204:09 pmRNSHolding(s) in Company
29th May 20202:40 pmRNSHolding(s) in Company
29th May 20207:00 amRNSNotice of Trading Update
28th May 202011:06 amRNSSecond Price Monitoring Extn
28th May 202011:00 amRNSPrice Monitoring Extension
28th May 20207:00 amRNSContract with Roche to Profile Autoantibodies
21st May 20207:00 amRNSEarlyCDT Lung Partnership Contract Signed
14th May 20207:00 amRNSFeatured Presentation at ASCO 2020 Virtual Meeting
12th May 20207:00 amRNSDrug Development Collaboration Agreement Signed
6th May 20208:56 amRNSPDMR Dealing
4th May 20205:08 pmRNSDirectorate Change
1st May 202010:32 amRNSGrant of Options and PDMR notification
24th Apr 20203:59 pmRNSDirector/PDMR Shareholding
7th Apr 202011:41 amRNSPDMR Dealing
1st Apr 202010:31 amRNSPDMR Dealing
25th Mar 202012:42 pmRNSPDMR Dealing
20th Mar 20202:09 pmRNSHolding(s) in Company
18th Mar 20205:42 pmRNSHolding(s) in Company
18th Mar 202012:19 pmRNSPDMR Dealing
17th Mar 202010:24 amRNSNICE concludes review of EarlyCDT Lung
13th Mar 202011:42 amRNSIssue of Equity
12th Mar 20206:31 pmRNSPDMR / PCA Dealings
4th Mar 20207:00 amRNSUS Commercial Launch
2nd Mar 20203:35 pmRNSDirector/PDMR's Dealing
21st Feb 20207:00 amRNS‘Winning in Business in Spain’ Award
18th Feb 202011:06 amRNSSecond Price Monitoring Extn
18th Feb 202011:00 amRNSPrice Monitoring Extension
14th Feb 20204:41 pmRNSSecond Price Monitoring Extn
14th Feb 20204:35 pmRNSPrice Monitoring Extension
14th Feb 202011:55 amRNSHolding(s) in Company
14th Feb 202011:05 amRNSSecond Price Monitoring Extn
14th Feb 202011:00 amRNSPrice Monitoring Extension
12th Feb 20207:00 amRNSHalf Year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.